- Home
- Publications
- Publication Search
- Publication Details
Title
Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 17, Issue 11, Pages 1158-1167
Publisher
Informa UK Limited
Online
2016-09-22
DOI
10.1080/15384047.2016.1235663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein
- (2015) N. Koshikawa et al. CANCER RESEARCH
- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
- (2015) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
- (2015) D. J. DiLillo et al. Cancer Immunology Research
- Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
- (2015) Valentin Goede et al. Oncology Research and Treatment
- Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas
- (2014) Marcus Remer et al. Immunotherapy
- Targeting CD137 enhances the efficacy of cetuximab
- (2014) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- KIR/HLA Interactions Negatively Affect Rituximab- but Not GA101 (Obinutuzumab)-Induced Antibody-Dependent Cellular Cytotoxicity
- (2014) G. Terszowski et al. JOURNAL OF IMMUNOLOGY
- CDD: NCBI's conserved domain database
- (2014) Aron Marchler-Bauer et al. NUCLEIC ACIDS RESEARCH
- Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
- (2014) Lin-Fang Wang et al. ONCOLOGY REPORTS
- EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
- (2014) B. Miao et al. Cancer Discovery
- The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
- (2014) Ross Stewart et al. Journal for ImmunoTherapy of Cancer
- Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
- (2013) R. M. Srivastava et al. CLINICAL CANCER RESEARCH
- EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion
- (2013) Nami Sugiyama et al. JOURNAL OF CELL BIOLOGY
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab
- (2012) C. A. Gerdes et al. CLINICAL CANCER RESEARCH
- Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
- (2012) Ruth Holm et al. International Journal of Medical Sciences
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- (2012) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
- (2011) William M. Merritt et al. CANCER BIOLOGY & THERAPY
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- (2010) H. E. Kohrt et al. BLOOD
- The Metastasis-Associated microRNA miR-516a-3p Is a Novel Therapeutic Target for Inhibiting Peritoneal Dissemination of Human Scirrhous Gastric Cancer
- (2010) Yoshifumi Takei et al. CANCER RESEARCH
- Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck
- (2010) Yong Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung Cancer
- (2009) J. M. Brannan et al. CLINICAL CANCER RESEARCH
- EFNA1 ligand and its receptor EphA2: Potential biomarkers for hepatocellular carcinoma
- (2009) Xiang-Dan Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients
- (2008) Wei-Jie Yuan et al. DIGESTIVE DISEASES AND SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started